Latest Shareholder Meeting News

Sayona Mining has updated its timetable for the merger with Piedmont Lithium, conditional placement, and share consolidation, aiming to simplify and speed up the process pending shareholder approval.

MAC Copper Limited has scheduled a key court hearing on July 30 to progress Harmony Gold’s recommended acquisition, moving closer to shareholder votes and regulatory approvals.

Mad Paws Holding Limited has agreed to be acquired by US-based Rover Group for $62 million, with shareholders set to receive a significant premium. The deal includes divestment of Mad Paws’ Pet Chemist business and closure of other e-commerce operations.

Insignia Financial has agreed to a $4.80 per share acquisition offer from CC Capital, representing a 56.9% premium over its recent share price. The Board unanimously recommends the scheme, pending regulatory and shareholder approvals.

RareX Limited has successfully raised A$2 million through a share placement at a premium, positioning itself to advance exploration and development across key rare earths projects in Australia and Kenya.

Dundas Minerals has secured a substantial 612 square kilometre tenement package in the underexplored Gerry Well greenstone belt, positioning itself as a key gold explorer in Western Australia’s northern goldfields.

Resolution Minerals has addressed ASX concerns over recent share price and volume spikes, attributing the activity to ongoing developments in its US Horse Heaven project acquisition.

Silk Logistics Holdings has scheduled its shareholder meeting for August 1 to vote on the proposed $2.14 per share acquisition by DP World Australia, with an independent expert reaffirming the deal’s fairness.

Pacific Edge Limited has opened a $5 million Share Purchase Plan at $0.10 per share, conditional on shareholder approval of a prior $16.1 million Placement. The capital raise aims to extend the company’s cash runway and accelerate US market adoption of its bladder cancer diagnostic tests amid Medicare non-coverage.

Pacific Edge Limited (ASX – PEB) has announced a securities purchase plan (SPP) aiming to raise up to NZD 5 million, contingent on shareholder approval of a prior NZD 16 million placement. The move is designed to bolster working capital amid ongoing growth initiatives.

NSX Limited has updated its Scheme Implementation Deed with CNSX Markets Inc., extending the shareholder approval deadline and allowing greater flexibility in acquisition structuring.

Imugene Limited has completed a $22.5 million institutional placement and launched a $15 million Share Purchase Plan, both featuring attaching options, to fund its azer-cel clinical program through a pivotal trial in 2026.